Aptamer therapeutics useful in the treatment of complement-related disorders
US11913000B2 · kind B2 · utility
0Cited by
83References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 12, 2021 |
| Grant date | Feb 27, 2024 |
| Priority date | — |
| Expiry date | May 21, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/3533
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.